Abstract
Signaling through the T cell receptor must be accompanied by costimulatory signals for the differentiation of naive T cells to cytokine-producing effector T helper cells. The costimulatory signal through CD28 is required for T cell activation resulting in increased interleukin (IL)-2 production in vitro, but its role in the production of IL-4 and in the in vivo response is still unclear. We have examined the effects of blocking CTLA-4 (the CD28 homologue) ligand interactions on the in vivo development of IL-4-producing T helper effector cells during a primary mucosal immune response to the nematode parasiteHeligmosomoides polygyrus and during a primary systemic immune response to immunogenic anti-IgD antibodies. Our results demonstrate that CD28 and/or CTLA-4 signaling is required for T cell priming leading to IL-4 cytokine production, B cell activation, and IgE secretion during both immune responses, suggesting that other signaling molecules do not substitute for these molecules in either of these two different immune responses. Furthermore, the CD28 ligands, B7-1 and B7-2, can substitute for each other in providing the required T cell costimulatory ligand interactions during the primary immune response toH. polygyrus. In contrast, memory T cells during the challenge immune response do not require CD28/CTLA-4 ligand interactions for TL-4 production and T helper effector function. *** DIRECT SUPPORT *** A02GS028 00003
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1993;71:1065–1068.
June CH, Ledbetter JA, Linsley PS, Thompson CB: Role of CD28 receptor in T cell activation. Immunol Today 1989;58:271.
Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191–212.
Jenkins MK, Johnson JG: Molecules involved in T-cell costimulation. Curr Opin Immunol 1993;5:361–367.
Lenschow DJ, Bluestone JA: T cell co-stimulation and in vivo tolerance. Curr Opin Immunol 1993;5:747–752.
Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH: Molecular events in the induction of a nonresponsive state in IL-2 producing helper T lymphocyte clones. Proc Natl Acad Sci USA 1987;84:5409–5413.
DeSilva DR, Urdahl KB, Jenkins MK: Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 1991;147:3261–3267.
Holsti MA, McArthur J, Allison JP, Raulet D: Role of IL-6, IL-1 and CD28 signaling in response of mouse CD4+T cells to immobilized anti-TCR monoclonal antibody. J Immunol 1994;152:1618–1628.
Hubbe M, Altevogt P: Heat-stable antigen/CD24 on mouse T lymphocytes: Evidence for a costimulatory function. Eur J Immunol 1994;24:731–737.
Johnson JG, Jenkins MK: Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction. J Immunol 1994;152:429–437.
Damle NK, Klussman K, Linsley PS, Aruffo A, Ledbetter JA: Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol 1992;149:2541–2548.
Damle NK, Klussman K, Aruffo A: Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. J Immunol 1992;148:665–671.
Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities CTLA-4 receptors. Immunity 1994; 1:793–801.
Linsley PS, Brady W, Grossmaire L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T-cell proliferation and interleukin-2 mRNA accumulation. J Exp Med 1991;173:721–730.
Norton SD, Zuckermann L, Urdahl KB, Shefner R, Miller J, Jenkins MK: The CD28 ligand enhances IL-2 production by providing costimulatory signal to T cells. J Immunol 1992;149:1556–1561.
Reiser H, Freeman GJ, Wolf ZB, Gimmi CD, Benacerraf B, Nadler LM: Murine B7 antigen provides and efficient costimulatory signal for activation of murine T lymphocytes via the T cell receptor/CD3 complex. Proc Natl Acad Sci USA 1992;89;271–275.
Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 1992;356:607–609.
Fraser JD, Irving BA, Crabtree GR, Weiss A: Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CE28. Science 1991;251:313–316.
Kurt-Jones EA, Hamberg S, Ohara J, Paul WE, Abbas AK: Heterogeneity of helper/inducer T lymphocytes: I: Lymphokine production and lymphokine responsiveness. J Exp Med 1987;166:1774–1787.
Greenbaum LA, Horowitz JB, Woods A, Pasqualini T, Reich E, Bottomly K: Cloned Th2 cells will respond to IL-4 but this response is dependent on the addition of IL-L. J Immunol 1988;140:1555–1560.
Weaver CT, Unanue ER: The costimulatory function of antigen-presenting cells. Immunol Today 1990; 11:49–55.
Johnson JG, Jenkins MK: Co-stimulatory functions of antigen-presenting cells. J Invest Dermatol 1992;99:62S-65S.
McArthur JG, Raulet DH: CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med 1993;178:1645–1653.
Tan P, Anasetti C, Jansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA, Linsley PS: Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993;177:165–173.
Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561–569.
Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Olumura K, Ito D, Azuma M: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97–105.
Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VA, Ke XY, Gray GS, Nadler LM: CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995;92:811–815.
June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1993;15:321–331.
Lindsten T, Lee KP, Harris ES, Ptryniak B, Craighead N, Reynolds PJ, Lombard DB, Freeman GJ, Nadler LM, Gray GS, Thompson CB, June CH: Characterization of CTLA-4 structure and expression on human T cells. J Immunol 1993; 151:3489–3499.
Boussiotis VA, Freeman GJ, Gribbon JG, Daley J, Gray G, Nadler LM: Activated human B lymphocytes express three CTLA-4 counter-receptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993;90:11059–11063.
Wallace PM, Rodgers JN, Leytze GM, Johnson JS: Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J Immunol 1995;154:5885–5895.
Linsley PS, Wallace PM, Johnson J, Givson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA: Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992;257:792–795.
Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag JR, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic islet grafts induced by CTLA4-Ig. Science 1992;257:789–792.
Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA4Ig. Science 1994;265:1225–1227.
Lu P, Zhou X, Chen SJ, Moorman M, Morris SC, Finkelman FD, Linsley P, Urban JF, Gause WC: CTLA-4 ligands are required in an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med 1994;180:693–698.
Lu P, Zhou X, Chen S, Moorman M, Schoneveld A, Morris S, Finkelman FD, Linsley P, Claassen E, Gause WC: Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a systemic in vivo immune response. J Immunol 1995; 154:1078–1087.
Urban JR Jr, Katona IM, Finkelman FD:Heligmosomoides polygyrus: CD4+but not CD8+T cells regulate the IgE response and protective immunity in mice. Exp Parasitol 1991;73:500–511.
Svetic A, Madden KB, Zhou XD, Lu P, Katona IM, Finkelman FD, Urban JF, Gause WC: A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol 1993;150:3434–3441.
Finkelman FD, Scher I, Mond JJ, Kung JT, Metcalf ES: Polyclonal activation of the murine immune system by an antibody to IgD. I: Increase in cell size and DNA synthesis. J Immunol 1982;129:629–637.
Finkelman FD, Smith J, Villacreses N, Metcalf ES: Polyclonal activation of the murine immune system by an antibody to IgD: Influence of dose of goat anti-mouse δ and normal goat IgG on B lymphocyte proliferation and differentiation. Eur J Immunol 1985;15:315–320.
Finkelman FD, Ohara J, Goroff DK, Smith J, Villacreses N, Mond JJ, Paul WE: Production of BSF-1 during an in vivo, T-dependent immune response. J Immunol 1986; 137:2878–2885.
Finkelman FD, Malek TR, Shevach EM, Mond JJ: In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes. J Immunol 1986;137:2252–2259.
Svetić A, Finkelman FD, Jian YC, Dieffenbach CW, Scott DE, McCarthy KF, Steinberg AD, Gause WC: Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 1991;147:2391–2397.
Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303–333.
Finkelman FD, Svetić A, Gresser I, Snapper C, Holmes J, Trotta PP, Katona IM, Gause WC: Regulation by IFN-α of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 1991; 174:1179–1188.
Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, Hubbard BR, Gause WC, Urban JF: Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994;179:1563–1572.
Urban JF, Madden KB, Svetić A, Cheever A, Trotta PP, Gause WC, Katona IM, Finkelman FD: The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev 1992;127:205–220.
Kim J, Woods A, Becker-Dunn E, Bottomly K: Distinct functional phenotypes of clone Ia-restricted helper T cells. J Exp Med 1985;162:188–201.
Weaver CT, Hawrylowica CM, Unanue ER: T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci USA 1988;85:8181–8185.
Lichtman AH, Chin J, Schmidt AJ, Abbas AK: Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci USA 1988;85:9699–9703.
Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA: The heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med 1992;175:437–445.
Springer TA: Adhesion receptors of the immune system. Nature 1990; 346:425–434.
Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ: Biological role of CD2, CD4, and CD8 in T cell activation. Annu Rev Immunol 1989;7:579–599.
Kobata T, Agematsu K, Kameoka J, Schlossman SF, Morimoto C: CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation. J Immunol 1994; 153:5422–5432.
Damle NK, Klussman K, Linsley PS, Aruffo A: Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J Immunol 1992;148:1985–1992.
Ronchese F, Hausmann B, Hubele S, Lane P: Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo. J Exp Med 1994;179:809–817.
Norton SD, Zuckermann L, Urdahl KB, Shefner R, Miller J, Jenkins MK: The CD28 ligand enhances IL-2 production by providing costimulatory signal to T cells. J Immunol 1992;149:1556–1561.
Jenkins MK, Taylor PS, Norton SD, Urdahl KB: CD28 delivers a costimulatory signal involved in antigen specific IL-2 production by human T cells. J Immunol 1991;147:2461–2466.
June CH, Ledbetter JA, Gillespic MM, Lindsten T, Thompson CB: T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987; 7:4472–4481.
Seder RA, Germain RN, Linsley PS, Paul WE: CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J Exp Med 1994;179:299–304.
Via CS, Finkelman FD: Anti-IL2 tratment in vivo converts acute murine graft-vs-host disease (GVHD) to a lupus-like disease (abstract). FASEB J 1991;5:1599.
Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A: Analysis of cytokine gene mRNA expression during primary granuloma formation induced by egs ofSchistosoma mansoni. J Immunol 1993;151:1430–1440.
Croft M, Bradley LM, Swain SL: Naive versus memory CD4 T cell response to antigen: Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994;152:2675–2685.
Corry DB, Reiner SL, Linsley PS, Locksley RM: Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J Immunol 1994;153:4142–4148.
Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181:1869–1874.
Morris SC, Lees A, Finkelman FD: In vivo activation of naive T cells by antigen-presenting cells. J Immunol 1994;152:3777–3785.
Swain SL, McKenzie DT, Weinberg AD, Hancock W: Characterization of T helper 1 and 2 cell subsets in normal mice: Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol 1988;141:3445–3455.
Ben-Sasson SZ, Le-Gros G, Conrad DH, Finkelman FD, Paul WE: IL-4 production by T cells from naive donors: IL-2 is required for IL-4 production. J Immunol 1990;145:1127–1136.
Ho WY, Cooke MP, Goodnow CC, Davis MM: Resting and anergic B cells are defective in CD28-dependent costimulation of naive T cells. J Exp Med 1994;179:1539–1549.
Svetić A, Jian YC, Lu P, Finkelman FD, Gause WC:Brucella abortus induces a novel cytokine gene expresson characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int Immunol 1993;5:877–884.
Wang SC, Zeevi A, Jordan ML, Simmons RL, Tweardy DJ: FK506, rapamycin, and cyclosporine: Effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc 1991;23:2920–2922.
Fiorentino DF, Zlotnik A, Mosmann RR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815–3822.
O'Garra A, Stapleton G, Dhar V, Pearce M, Schumacher J, Rugo H, Barbis D, Stall A, Cupp J, Moore K, Vieriera P, Mosmann T, Whitmore A, Arnold L, Haughton G, Howard M: Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990;2:821–832.
Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081–2095.
Ding L, Linsley PS, Huang L, Germain RN, Shevach EM: IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the upregulation of B7 expression. J Immunol 1993;150:180a.
Sethna MP, Parijs LV, Sharpe AH, Abbas AK, Freeman GJ: A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1994;1:415–421.
Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405–413.
Lenshow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nababvi N, Herold KC, Bluestone JA: Differential effect of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181:1145–1155.
Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ: Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J Exp Med 1994;180:631–640.
Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152:5208–5219.
Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, Muramatsu S, Hodes RJ, Steinman RM: The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849–1860.
Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimbher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707–718.
Scott P: IL-12: Initiation cytokine for cell-mediated immunity. Science 1993;1160:496–497.
Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadlier LM: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1994;2:523–532.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gause, W.C., Urban, J.F., Linsley, P. et al. Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells. Immunol Res 14, 176–188 (1995). https://doi.org/10.1007/BF02918215
Issue Date:
DOI: https://doi.org/10.1007/BF02918215